Submitted by Anonymous (not verified) on 17 October 2025 - 11:40
Opinion/decision on a Paediatric investigation plan (PIP): Spevigo, spesolimab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Congenital, familial and genetic disorders, PIP number: P/0341/2024
Source: